<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Marild K</submitter><funding>Vetenskapsrådet</funding><funding>NIDDK NIH HHS</funding><funding>Svenska Sällskapet för Medicinsk Forskning</funding><pagination>1549-1560</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11599792</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>60(11-12)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Individuals with inflammatory bowel disease (IBD) are at increased risk of fracture. It is unclear if this risk varies by recent histological activity.&lt;h4>Aims&lt;/h4>To determine the fracture risk in IBD during periods with and without histological inflammation.&lt;h4>Methods&lt;/h4>We studied a nationwide cohort of 54,591 individuals diagnosed with IBD in 1990-2016 with longitudinal data on ileo-colorectal biopsies. Fractures were identified by inpatient and hospital-based outpatient diagnoses. We derived Cox regression estimated hazard ratios (HRs) for fracture during 12 months following a histological inflammation (vs. histological remission) record after adjusting for socio-demographics, comorbidities, IBD duration, IBD-related surgery and hospitalization. We adjusted sensit</pubmed_abstract><journal>Alimentary pharmacology &amp; therapeutics</journal><pubmed_title>A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk.</pubmed_title><pmcid>PMC11599792</pmcid><funding_grant_id>2020‐01980</funding_grant_id><funding_grant_id>2020-01980</funding_grant_id><funding_grant_id>2020-02002</funding_grant_id><funding_grant_id>K23 DK124570</funding_grant_id><funding_grant_id>2020‐02002</funding_grant_id><pubmed_authors>Axelrad J</pubmed_authors><pubmed_authors>Bjork J</pubmed_authors><pubmed_authors>Olen O</pubmed_authors><pubmed_authors>Hjortswang H</pubmed_authors><pubmed_authors>Soderling J</pubmed_authors><pubmed_authors>Bengtsson J</pubmed_authors><pubmed_authors>Michaelsson K</pubmed_authors><pubmed_authors>Nordenvall C</pubmed_authors><pubmed_authors>Karling P</pubmed_authors><pubmed_authors>Olsson M</pubmed_authors><pubmed_authors>Ludvigsson JF</pubmed_authors><pubmed_authors>Andersson M</pubmed_authors><pubmed_authors>Jaghult S</pubmed_authors><pubmed_authors>Forss A</pubmed_authors><pubmed_authors>SWIBREG Study Group</pubmed_authors><pubmed_authors>Marild K</pubmed_authors><pubmed_authors>Rejler M</pubmed_authors><pubmed_authors>Eberhardson M</pubmed_authors><pubmed_authors>Fagerberg UL</pubmed_authors><pubmed_authors>Strid H</pubmed_authors><pubmed_authors>Halfvarson J</pubmed_authors><pubmed_authors>Myrelid P</pubmed_authors><pubmed_authors>Grip O</pubmed_authors></additional><is_claimable>false</is_claimable><name>A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk.</name><description>&lt;h4>Background&lt;/h4>Individuals with inflammatory bowel disease (IBD) are at increased risk of fracture. It is unclear if this risk varies by recent histological activity.&lt;h4>Aims&lt;/h4>To determine the fracture risk in IBD during periods with and without histological inflammation.&lt;h4>Methods&lt;/h4>We studied a nationwide cohort of 54,591 individuals diagnosed with IBD in 1990-2016 with longitudinal data on ileo-colorectal biopsies. Fractures were identified by inpatient and hospital-based outpatient diagnoses. We derived Cox regression estimated hazard ratios (HRs) for fracture during 12 months following a histological inflammation (vs. histological remission) record after adjusting for socio-demographics, comorbidities, IBD duration, IBD-related surgery and hospitalization. We adjusted sensit</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-11T05:18:49.508Z</modification><creation>2025-04-04T02:45:31.58Z</creation></dates><accession>S-EPMC11599792</accession><cross_references><pubmed>39308339</pubmed><doi>10.1111/apt.18275</doi></cross_references></HashMap>